BAXTER INTL INC's ticker is BAX and the CUSIP is 071813109. A total of 962 filers reported holding BAXTER INTL INC in Q3 2014. The put-call ratio across all filers is 1.07 and the average weighting 0.4%.
About BAXTER INTL INC
Baxter International Inc. is a global healthcare company that specializes in developing and manufacturing medical products and therapies. The company has a long history of innovation and has been at the forefront of developing life-saving treatments for patients around the world.
Baxter's product portfolio includes a wide range of medical devices, pharmaceuticals, and biotechnology products. The company's products are used in hospitals, clinics, and other healthcare settings to treat a variety of conditions, including hemophilia, immune disorders, kidney disease, and other chronic and acute medical conditions.
Baxter's commitment to innovation has helped the company maintain a strong position in the healthcare industry. The company invests heavily in research and development, and has a strong pipeline of new products in development.
Baxter's leadership team is also a key strength of the company. The CEO, José Almeida, has a strong track record of success in the healthcare industry, and has been instrumental in driving the company's growth and success.
Overall, Baxter International Inc. is a strong and innovative company that is well-positioned to continue delivering value to patients, healthcare providers, and investors alike. With a strong product portfolio, a commitment to innovation, and a talented leadership team, Baxter is a company that investors should keep an eye on in the years to come.
It's important to note that this information is for educational purposes only and has not been fact-checked. As with any investment, it's important to do your own research and consult with a financial advisor before making any investment decisions.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $677,584 | -26.8% | 17,954 | -11.6% | 0.04% | -22.4% |
| Q2 2023 | $925,096 | +3.3% | 20,305 | -8.0% | 0.05% | -3.9% |
| Q1 2023 | $895,565 | -28.7% | 22,080 | -10.4% | 0.05% | -32.0% |
| Q4 2022 | $1,256,665 | -12.2% | 24,655 | -7.2% | 0.08% | -17.6% |
| Q3 2022 | $1,431,000 | -21.2% | 26,571 | -5.9% | 0.09% | -16.5% |
| Q2 2022 | $1,815,000 | -21.8% | 28,251 | -5.7% | 0.11% | -7.6% |
| Q1 2022 | $2,322,000 | -15.3% | 29,944 | -6.3% | 0.12% | -9.9% |
| Q4 2021 | $2,743,000 | +3.6% | 31,950 | -2.9% | 0.13% | -6.4% |
| Q3 2021 | $2,647,000 | -5.9% | 32,902 | -5.9% | 0.14% | -6.0% |
| Q2 2021 | $2,814,000 | -12.7% | 34,956 | -8.6% | 0.15% | -19.9% |
| Q1 2021 | $3,225,000 | +3.2% | 38,237 | -1.8% | 0.19% | -2.1% |
| Q4 2020 | $3,126,000 | -4.3% | 38,957 | -4.1% | 0.19% | -14.8% |
| Q3 2020 | $3,266,000 | -7.0% | 40,610 | -0.4% | 0.22% | -14.6% |
| Q2 2020 | $3,513,000 | +5.8% | 40,792 | -0.3% | 0.26% | -13.3% |
| Q1 2020 | $3,321,000 | -5.4% | 40,904 | -2.5% | 0.30% | +18.0% |
| Q4 2019 | $3,509,000 | -3.6% | 41,971 | +0.9% | 0.26% | -10.2% |
| Q3 2019 | $3,639,000 | +6.2% | 41,611 | -0.6% | 0.28% | +2.9% |
| Q2 2019 | $3,428,000 | -0.4% | 41,862 | -1.1% | 0.28% | -5.5% |
| Q1 2019 | $3,443,000 | +19.9% | 42,344 | -2.9% | 0.29% | +6.2% |
| Q4 2018 | $2,871,000 | -17.9% | 43,605 | -3.8% | 0.28% | -3.8% |
| Q3 2018 | $3,496,000 | +2.9% | 45,346 | -1.5% | 0.29% | -3.1% |
| Q2 2018 | $3,398,000 | +11.6% | 46,016 | -1.7% | 0.30% | +9.3% |
| Q1 2018 | $3,045,000 | -2.5% | 46,811 | -3.1% | 0.27% | -5.3% |
| Q4 2017 | $3,123,000 | +2.0% | 48,322 | -1.0% | 0.28% | -2.7% |
| Q3 2017 | $3,063,000 | -0.1% | 48,810 | -3.4% | 0.29% | -2.7% |
| Q2 2017 | $3,065,000 | +14.7% | 50,529 | -1.7% | 0.30% | +13.2% |
| Q1 2017 | $2,673,000 | +15.6% | 51,429 | -1.2% | 0.27% | +10.8% |
| Q4 2016 | $2,312,000 | -7.6% | 52,042 | -0.8% | 0.24% | -10.4% |
| Q3 2016 | $2,503,000 | +4.3% | 52,474 | +0.1% | 0.27% | -2.2% |
| Q2 2016 | $2,399,000 | +8.5% | 52,439 | -2.6% | 0.27% | +8.3% |
| Q1 2016 | $2,211,000 | -7.8% | 53,839 | -14.3% | 0.25% | -9.6% |
| Q4 2015 | $2,398,000 | +16.7% | 62,854 | +0.5% | 0.28% | +11.1% |
| Q3 2015 | $2,054,000 | -55.3% | 62,519 | -4.9% | 0.25% | -51.5% |
| Q2 2015 | $4,595,000 | +0.0% | 65,709 | -2.0% | 0.52% | -2.4% |
| Q1 2015 | $4,593,000 | -18.7% | 67,048 | -13.0% | 0.53% | -21.3% |
| Q4 2014 | $5,647,000 | +1.3% | 77,044 | -0.8% | 0.68% | -1.3% |
| Q3 2014 | $5,574,000 | +0.7% | 77,655 | +1.4% | 0.69% | -1.0% |
| Q2 2014 | $5,538,000 | +6.1% | 76,603 | +2.0% | 0.69% | -5.8% |
| Q4 2013 | $5,222,000 | +23.1% | 75,084 | +16.3% | 0.74% | +16.6% |
| Q3 2013 | $4,242,000 | -4.8% | 64,565 | +0.3% | 0.63% | -9.6% |
| Q2 2013 | $4,457,000 | – | 64,341 | – | 0.70% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| GENERATION INVESTMENT MANAGEMENT LLP | 21,171,371 | $1,817,350,000 | 7.47% |
| Soditic Asset Management LLP | 147,620 | $12,672,000 | 6.53% |
| NUANCE INVESTMENTS, LLC | 4,084,218 | $350,589,000 | 6.17% |
| PRAGMA GESTAO DE PATRIMONIO LTD | 145,000 | $12,447 | 5.96% |
| Veritas Asset Management LLP | 12,222,261 | $1,049,159,000 | 5.89% |
| Pavadi Capital LLC | 72,782 | $6,248,000 | 4.74% |
| Sonen Capital LLC | 48,907 | $4,198,000 | 4.06% |
| Glenview Capital Management | 2,182,422 | $187,339,000 | 3.99% |
| Dash Acquisitions Inc. | 103,963 | $8,924,000 | 3.87% |
| Avidity Partners Management LP | 1,765,000 | $151,508,000 | 3.21% |